EUVIMEDEUVIMED entdecken
Crossref

Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization

Jiaxin Li, Yalin Liu, Zheng Xiao, Chenyang Zang, Peihong Li, Bo Xiao, Luo Zhou

Immunogenetics · 2025

DOI: 10.1007/s00251-024-01360-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunogenetics, 2025. Verfasst von Jiaxin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Receptors, Interleukin-6, Genome-Wide Association Study, Autoimmune Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mendelian Randomization AnalysisReceptors, Interleukin-6Genome-Wide Association StudyAutoimmune DiseasesHumansPolymorphism, Single NucleotideCOVID-19Arthritis, RheumatoidAsthmaC-Reactive Protein

Stichwörter der Autor:innen

Autoimmune diseasesC-reactive proteinCausal associationInterleukin 6 receptor blockadeMendelian randomization

Substanzen

Receptors, Interleukin-6IL6R protein, humanC-Reactive Protein

Autor:innen und Institutionen

  • Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Clinical Nutrition, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Pathology, First Hospital of Changsha, Changsha, Hunan, China.
  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China. zhouluo@csu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Li, J., Liu, Y., Xiao, Z., Zang, C., Li, P., Xiao, B., & Zhou, L. (2025). Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization. Immunogenetics. https://doi.org/10.1007/s00251-024-01360-w

Vancouver

Li J, Liu Y, Xiao Z, Zang C, Li P, Xiao B, et al. Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization. Immunogenetics. 2025. doi:10.1007/s00251-024-01360-w

BibTeX
@article{Li2025,
  author = {Li, Jiaxin and Liu, Yalin and Xiao, Zheng and Zang, Chenyang and Li, Peihong and Xiao, Bo and Zhou, Luo},
  title = {Exploring the therapeutic potential of interleukin-6 receptor blockade in autoimmune diseases using drug target mendelian randomization},
  journal = {Immunogenetics},
  year = {2025},
  doi = {10.1007/s00251-024-01360-w}
}
Kostenlos starten →